The effect of bradykinin and the bradykinin antagonist Hoe 140 on kinematic parameters of human spermatozoa. 1996

C H Yeung, and B Spier, and T G Cooper, and P Nacke, and E Nieschlag
Institute of Reproductive Medicine, Münster, Germany.

Bradykinin (BK) has been suggested to be an active substance in the disputed therapeutic use of kallikrein to improve semen quality. The effects of exogenous BK and its antagonist Hoe 140, which acts on one of the bradykinin receptors (BK2), were examined in two groups of patients attending the fertility clinic: those with asthenozoospermia (group I) and normozoospermia (group II). Bradykinin (10nM-1 microM) added to washed human spermatozoa had no effect on most kinematic parameters and caused only a marginal increase (7%) in curvilinear velocity at 50 nM in group I patients; however, this increase was not suppressed by concomitant addition of the BK antagonist. The bradykinin antagonist itself had no effect on the percentage motility or kinematic motility parameters of washed human spermatozoa in either group of patients. The motility of spermatozoa in semen was also unaffected by the presence of the bradykinin antagonist. It is concluded that bradykinin does not act exogenously on washed spermatozoa nor endogenously on spermatozoa in semen to stimulate motility via BK2 receptors, regardless of the initial quality of the sperm motility.

UI MeSH Term Description Entries
D008297 Male Males
D001920 Bradykinin A nonapeptide messenger that is enzymatically produced from KALLIDIN in the blood where it is a potent but short-lived agent of arteriolar dilation and increased capillary permeability. Bradykinin is also released from MAST CELLS during asthma attacks, from gut walls as a gastrointestinal vasodilator, from damaged tissues as a pain signal, and may be a neurotransmitter. Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg,Bradykinin Acetate, (9-D-Arg)-Isomer,Bradykinin Diacetate,Bradykinin Hydrochloride,Bradykinin Triacetate,Bradykinin, (1-D-Arg)-Isomer,Bradykinin, (2-D-Pro)-Isomer,Bradykinin, (2-D-Pro-3-D-Pro-7-D-Pro)-Isomer,Bradykinin, (2-D-Pro-7-D-Pro)-Isomer,Bradykinin, (3-D-Pro)-Isomer,Bradykinin, (3-D-Pro-7-D-Pro)-Isomer,Bradykinin, (5-D-Phe)-Isomer,Bradykinin, (5-D-Phe-8-D-Phe)-Isomer,Bradykinin, (6-D-Ser)-Isomer,Bradykinin, (7-D-Pro)-Isomer,Bradykinin, (8-D-Phe)-Isomer,Bradykinin, (9-D-Arg)-Isomer,Arg Pro Pro Gly Phe Ser Pro Phe Arg
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013081 Sperm Motility Movement characteristics of SPERMATOZOA in a fresh specimen. It is measured as the percentage of sperms that are moving, and as the percentage of sperms with productive flagellar motion such as rapid, linear, and forward progression. Motilities, Sperm,Motility, Sperm,Sperm Motilities
D013094 Spermatozoa Mature male germ cells derived from SPERMATIDS. As spermatids move toward the lumen of the SEMINIFEROUS TUBULES, they undergo extensive structural changes including the loss of cytoplasm, condensation of CHROMATIN into the SPERM HEAD, formation of the ACROSOME cap, the SPERM MIDPIECE and the SPERM TAIL that provides motility. Sperm,Spermatozoon,X-Bearing Sperm,X-Chromosome-Bearing Sperm,Y-Bearing Sperm,Y-Chromosome-Bearing Sperm,Sperm, X-Bearing,Sperm, X-Chromosome-Bearing,Sperm, Y-Bearing,Sperm, Y-Chromosome-Bearing,Sperms, X-Bearing,Sperms, X-Chromosome-Bearing,Sperms, Y-Bearing,Sperms, Y-Chromosome-Bearing,X Bearing Sperm,X Chromosome Bearing Sperm,X-Bearing Sperms,X-Chromosome-Bearing Sperms,Y Bearing Sperm,Y Chromosome Bearing Sperm,Y-Bearing Sperms,Y-Chromosome-Bearing Sperms
D065168 Bradykinin Receptor Antagonists Compounds and drugs that inhibit ligand binding or cellular signaling by BRADYKININ RECEPTORS. Bradykinin Antagonist,Bradykinin Receptor Antagonist,Bradykinin Receptor Blocker,Bradykinin Receptor Inhibitor,Bradykinin Antagonists,Bradykinin Receptor Blockers,Bradykinin Receptor Inhibitors,Antagonist, Bradykinin,Antagonist, Bradykinin Receptor,Antagonists, Bradykinin,Antagonists, Bradykinin Receptor,Blocker, Bradykinin Receptor,Inhibitor, Bradykinin Receptor,Inhibitors, Bradykinin Receptor,Receptor Antagonist, Bradykinin,Receptor Antagonists, Bradykinin,Receptor Blocker, Bradykinin,Receptor Blockers, Bradykinin,Receptor Inhibitor, Bradykinin,Receptor Inhibitors, Bradykinin

Related Publications

C H Yeung, and B Spier, and T G Cooper, and P Nacke, and E Nieschlag
January 1998, Andrologia,
C H Yeung, and B Spier, and T G Cooper, and P Nacke, and E Nieschlag
January 1992, Agents and actions. Supplements,
C H Yeung, and B Spier, and T G Cooper, and P Nacke, and E Nieschlag
October 1992, British journal of pharmacology,
C H Yeung, and B Spier, and T G Cooper, and P Nacke, and E Nieschlag
January 1993, British journal of pharmacology,
C H Yeung, and B Spier, and T G Cooper, and P Nacke, and E Nieschlag
April 1992, British journal of pharmacology,
C H Yeung, and B Spier, and T G Cooper, and P Nacke, and E Nieschlag
December 1992, The Journal of pharmacology and experimental therapeutics,
C H Yeung, and B Spier, and T G Cooper, and P Nacke, and E Nieschlag
January 1994, European journal of pharmacology,
C H Yeung, and B Spier, and T G Cooper, and P Nacke, and E Nieschlag
July 1998, The journal of peptide research : official journal of the American Peptide Society,
C H Yeung, and B Spier, and T G Cooper, and P Nacke, and E Nieschlag
January 1992, Peptides,
C H Yeung, and B Spier, and T G Cooper, and P Nacke, and E Nieschlag
February 1993, British journal of pharmacology,
Copied contents to your clipboard!